Centre for Process Innovation
VC Fund
Redcar, United Kingdom
Centre for Process Innovation is a VC fund in Redcar focused on Medical and Health Care. The Centre for Process Innovation (CPI) is a technology innovation center helps its clients develop, prove, prototype, and commercialize products and processes. It is a part of the High Value Manufacturing Catapult.The center provides assets which enable customers to demonstrate the process and prove it is feasible before investing in capitalequipment and training. New products and processes can be proven on paper, in the lab, and in the plant before being manufactured at an industrial scale.The CPI’s portfolio of services includes product and process development; prototyping, demonstration, and scale up; pilot production; fuel, feedstock, and materials investigation; manufacturability, process modeling, and simulation; economic evaluation, lifecycle analysis, and process economics; identification and engagement of key collaborators; and commercialization support and incubator space.It focuses on four technologies: industrial biotechnology and biorefining, printable electronics, biologics, and formulation and flexible manufacturing.The center serves various markets, including aerospace, defense, and security; automotive and transport; built environment; retail and consumer goods; energy; food and drink; materials and chemicals; personal care; pharmaceuticals; electronics and IT; specialty chemicals; and environment and water.The Centre for Process Innovation was founded in 2003 and is headquartered in Redcar, United Kingdom with presence in Darlington and County Durham.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Centre for Process Innovation invests in
Stages Centre for Process Innovation invests in
Countries Centre for Process Innovation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Dowle
|
|||
Frank Millar
|
|||
Jon Helliwell
|
|||
Neville Hamlin
|
|||
Nigel Perry
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Medical 3 (43%)
- Health Care 2 (29%)
- Biotechnology 2 (29%)
- Biopharma 1 (14%)
- CleanTech 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chris Dowle
Director of the National Biologics Manufacturing Centre
|
Director of the National Biologics Manufacturing Centre | Total investments: 0 | Find email | |
|
Frank Millar
CEO
|
CEO | Total investments: 0 | Find email | |
|
Jon Helliwell
Operations Support Director
|
Operations Support Director | Total investments: 0 | Find email | |
|
Neville Hamlin
Financial Director and Chief Operating Officer
|
Financial Director and Chief Operating Officer | Total investments: 0 | Find email | |
|
Nigel Perry
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CMD Technology
|
Cotton Mouton Diagnostics Ltd (CMD), a Cardiff based diagnostics company, has developed a rapid and novel point-of-need analytical platform based on proprietary intellectual property. This technology has initially been applied to the rapid and sensitive detection of bacterial endotoxins in the large and expanding pharmaceutical quality controlmarket.Subsequently the technology will target an un-met need in the diagnosis and monitoring of biomarkers at point-of-care (PoC) where it will compete in the growing $16bn PoC testing market.The technology is readily applicable to pre-hospital care, an under-utilised area of medical diagnostics, where for many clinical conditions rapid-diagnosis and treatment is critical if favourable patient outcomes are to be delivered.CMD Ltd has filed three patent families protecting its nano-sensing technology, the first of which has been granted in USA, Europe and China. | $667.7K / Corporate Round / Jul 29, 2025 | |
Aisthesis Medical
|
Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes. | $37.9K / Grant / Feb 17, 2025 | |
DEScycle
|
DEScycle is a startup that deploys next generation metals processing infrastructure to recover metals from waste streams, such as e-waste. Their mission is to turn domestic waste streams into sovereign metal supply. | $12.9M / Series A / Nov 18, 2024 | |
Floreon
|
Floreon is a specially formulated compound, which is added to standard bioplastic, polylactic acid (PLA) to create an innovative material with a sustainable origin and a range of end of life options.It was created from a desire for a greener, safer form of plastic. Unhappy with the options available they decided to develop their own. After fouryears and a Knowledge Transfer Partnership (KTP) with the University of Sheffield a unique, environmentally friendly, fully compostable and high performing bioplastic was born. | $318.2K / May 30, 2024 | |
|
DEScycle
|
DEScycle is a startup that deploys next generation metals processing infrastructure to recover metals from waste streams, such as e-waste. Their mission is to turn domestic waste streams into sovereign metal supply. | $6M / Seed / Apr 18, 2023 | |
MetalloBio
|
Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance. | $36.4K / Pre-Seed / Jun 29, 2022 | |
Qualus
|
Qualus is the provider of sustainable solutions to the leather industry, has secured £1 million of financing in a round led by Irrus Investments, an Ireland based angel syndicate. Co-investors in the round include CPI Enterprises and angels from Cambridge Capital Group and Harvard Business School Alumni Angels of London. | $1.4M / Angel / Jun 01, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Centre for Process Innovation invest in?
Centre for Process Innovation invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Angel stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Centre for Process Innovation?
Public channels for Centre for Process Innovation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Centre for Process Innovation?
The team at Centre for Process Innovation includes Chris Dowle (Director of the National Biologics Manufacturing Centre), Frank Millar (CEO) and Jon Helliwell (Operations Support Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
